Management of early-stage triple-negative breast cancer: recommendations of a panel of experts from the Brazilian Society of Mastology
Authors:
- Ruffo Freitas-JuniorRFRuffo Freitas-Junior
- Vilmar Marques de OliveiraVOVilmar Marques de Oliveira
- Antonio Luiz FrassonAFAntonio Luiz Frasson
- Francisco Pimentel CavalcanteFCFrancisco Pimentel Cavalcante
- Fabio Postiglione MansaniFMFabio Postiglione Mansani
- AndrÉ MattarAMAndrÉ Mattar
- Felipe Pereira ZerwesFZFelipe Pereira Zerwes
- Adriana Magalhães de Oliveira FreitasAFAdriana Magalhães de Oliveira Freitas
- Alessandra Borba Anton de SouzaASAlessandra Borba Anton de Souza
- Andrea P. DaminADAndrea P. Damin
- Annamaria Massahud Rodrigues dos SantosASAnnamaria Massahud Rodrigues dos Santos
- Carlos Alberto RuizCRCarlos Alberto Ruiz
Open Access
- 22 November 2022
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-12
Abstract
Triple-negative breast cancer (TNBC) is a heterogenous subtype involving different patterns of behavior and clinical course, demanding a complex, individualized sequence of treatment. The knowledge and attitudes of the affiliated members of the Brazilian Society of Mastology regarding TNBC were evaluated and a consensus regarding management and treatment was reached. Affiliates completed a survey involving 44 objective questions. In addition, a specialist meeting was held with 27 experts and 3 ad hoc consultants. The panelists completed the survey before and after brainstorming. Answers achieving 70% of agreement were considered consensual. The chi-square test was used to compare answers between panelists and affiliates and the Kappa coefficient to calculate agreement. Consensus among the panelists increased from 26 (59.1%) to 32 questions (72.7%) following brainstorming (p = 0.17), including 7/10 questions on systemic treatment. Among the affiliates, consensus was achieved for 24 questions (54.5%), resulting in moderate agreement (κ = 0.445). Neoadjuvant chemotherapy should be indicated for almost all cases (except cT1a-b N0) and should include platinum agents. When indicated, immunotherapy is part of the standard of care. The panel reaffirmed the concept of no ink on tumor as indicative of adequate margins and the possibility of sentinel lymph node biopsy for cN1 patients who become cN0 following neoadjuvant therapy. Controversies remain on combining immunotherapy with capecitabine/olaparib in pertinent cases. Expert consensus was achieved for > 70% of the questions, with moderate agreement between panelists and affiliates. Educational interventions on systemic breast cancer treatment affected decision-making in 60% of the questions.Keywords
This publication has 32 references indexed in Scilit:
- Evolving indications and long‐term oncological outcomes of risk‐reducing bilateral nipple‐sparing mastectomyBJS Open, 2018
- Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trialsThe Lancet Oncology, 2018
- Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2017
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategiesThe Lancet, 2017
- Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trialThe Lancet Oncology, 2014
- Society of Surgical Oncology–American Society for Radiation Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Stages I and II Invasive Breast CancerJournal of Clinical Oncology, 2014
- Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing StudiesPLOS Medicine, 2011
- Evaluation of Residual Glandular Tissue After Skin-Sparing MastectomiesAnnals of Surgical Oncology, 2005
- Type I Error Rate Comparisons of Post Hoc Procedures for I j Chi-Square TablesEducational and Psychological Measurement, 2000
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977